PharmacyCodes



Captolane en es it fr

Captolane Brand names, Captolane Analogs

Captolane Brand Names Mixture

  • No information avaliable

Captolane Chemical_Formula

C9H15NO3S

Captolane RX_link

http://www.rxlist.com/cgi/generic/captop.htm

Captolane fda sheet

Captolane msds (material safety sheet)

Captolane MSDS

Captolane Synthesis Reference

D. W. Cushman, U.S. Pat. 4,046,889 (1977)

Captolane Molecular Weight

217.286 g/mol

Captolane Melting Point

106oC

Captolane H2O Solubility

Freely soluble

Captolane State

Solid

Captolane LogP

0.546

Captolane Dosage Forms

Tablet (12.5 mg, 25 mg, 50 mg, or 100 mg)

Captolane Indication

For the treatment of hypertension. It may be used alone or in combination with thiazide diuretics.

Captolane Pharmacology

Captopril, an angiotensin-converting enzyme (ACE) inhibitor, is used to treat hypertension, congestive heart failure, and renal syndromes such as diabetic nephropathy and scleroderma. The adverse effect and pharmacokinetic limitations of captopril stimulated the development enalapril and subsequent ACE inhibitors.

Captolane Absorption

75% without food (the presence of food in the gastrointestinal tract reduces absorption by about 30 to 40 percent).

Captolane side effects and Toxicity

Symptoms of overdose include coma, lethargy, low blood pressure, sluggishness, and stomach and intestinal irritation and hyperactivity.

Captolane Patient Information

Patients should be advised to immediately report to their physician any signs or symptoms suggesting angioedema (e.g., swelling of face, eyes, lips, tongue, larynx and extremities; difficulty in swallowing or breathing; hoarseness) and to discontinue therapy.

Patients should be told to report promptly any indication of infection (e.g., sore throat, fever),which may be a sign of neutropenia, or of progressive edema which might be related to proteinuria and nephrotic syndrome.

All patients should be cautioned that excessive perspiration and dehydration may lead to an excessive fall in blood pressure because of reduction in fluid volume. Other causes of volume depletion such as vomiting or diarrhea may also lead to a fall in blood pressure; patients should be advised to consult with the physician.

Patients should be advised not to use potassium-sparing diuret-ics, potassium supplements or potassium-containing salt substitutes without consulting their physician.

Patients should be warned against interruption or discontinuation of medication unless instructed by the physician.

Heart failure patients on captopril therapy should be cautioned against rapid increases in physical activity.

Patients should be informed that captopril should be taken one hour before meals.

Captolane Organisms Affected

Humans and other mammals